These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1850854)

  • 21. Control of endothelial function by nucleotides: multiple receptors and transduction mechanisms.
    Pirotton S; Motte S; Côte S; Boeynaems JM
    Cell Signal; 1993 Jan; 5(1):1-8. PubMed ID: 8383991
    [No Abstract]   [Full Text] [Related]  

  • 22. Purinergic signaling as a target for emerging neurotherapeutics.
    Engel T; Sperlagh B
    Brain Res Bull; 2019 Sep; 151():1-2. PubMed ID: 31163189
    [No Abstract]   [Full Text] [Related]  

  • 23. [ATP receptor and neurotransmitter release].
    Inoue K; Nakazawa K
    Seikagaku; 1992 Mar; 64(3):172-7. PubMed ID: 1352320
    [No Abstract]   [Full Text] [Related]  

  • 24. Purinergic Signalling in Immune System Regulation in Health and Disease.
    Sévigny J; Martín-Satué M; Pintor J
    Mediators Inflamm; 2015; 2015():106863. PubMed ID: 26300587
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeting purinergic signaling for perioperative organ protection.
    Eltzschig HK
    Anesthesiology; 2013 May; 118(5):1001-4. PubMed ID: 23360900
    [No Abstract]   [Full Text] [Related]  

  • 26. [Extracellular adenosine triphosphate, its sources and the effect on animal cell functions].
    Dmitrenko NP
    Ukr Biokhim Zh (1978); 1990; 62(2):3-13. PubMed ID: 2195731
    [No Abstract]   [Full Text] [Related]  

  • 27. Modulation of inflammation by extracellular nucleotides.
    Boeynaems JM; Communi D
    J Invest Dermatol; 2006 May; 126(5):943-4. PubMed ID: 16619009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting the Purinergic Signaling Puzzle.
    Pérez-Sen R; Delicado EG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Change in the content and rate of phospholipid metabolism in endocrine glands in experimental hypoxic hypoxia in rats].
    Gribanov GA
    Patol Fiziol Eksp Ter; 1968; 12(2):32-4. PubMed ID: 5264474
    [No Abstract]   [Full Text] [Related]  

  • 30. Purinergic Signalling in Physiology and Pathophysiology.
    Sluyter R
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tribute to Prof. Geoffrey Burnstock: his contribution to acupuncture.
    Tang Y; Illes P
    Purinergic Signal; 2021 Mar; 17(1):71-77. PubMed ID: 33034832
    [No Abstract]   [Full Text] [Related]  

  • 32. Intraluminal autocrine purinergic signaling within cysts: implications for the progression of diseases that involve encapsulated cyst formation.
    Olteanu D; Hovater MB; Schwiebert EM
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F11-4. PubMed ID: 16940560
    [No Abstract]   [Full Text] [Related]  

  • 33. ExActa purinergic signalling.
    Persson PB
    Acta Physiol (Oxf); 2012 Jan; 204(1):3-5. PubMed ID: 22151956
    [No Abstract]   [Full Text] [Related]  

  • 34. Which iodolipids are involved in thyroid autoregulation: iodolactones or iodoaldehydes?
    Boeynaems JM; Van Sande J; Dumont JE
    Eur J Endocrinol; 1995 Jun; 132(6):733-4. PubMed ID: 7788014
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial overview: "Purinergic immune cell regulation reveals novel pharmacological targets".
    Junger W; Ledderose C
    Curr Opin Pharmacol; 2024 Apr; 75():102435. PubMed ID: 38277943
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ca(2+)-phospholipid-dependent protein kinases and their role in regulating metabolic processes].
    Ostapchenko LI
    Ukr Biokhim Zh (1978); 1995; 67(6):3-11. PubMed ID: 8867305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine receptors.
    Stiles GL
    J Biol Chem; 1992 Apr; 267(10):6451-4. PubMed ID: 1551861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Retinal Disorders with Purinergic Drugs: Beyond Receptors.
    Beckel JM; Lu W; Civan MM; Mitchell CH
    J Ocul Pharmacol Ther; 2016 Oct; 32(8):488-489. PubMed ID: 27754823
    [No Abstract]   [Full Text] [Related]  

  • 39. [Adenosine receptor ligands--drugs of the future?].
    Müller CE; Folkers G
    Pharm Unserer Zeit; 1989 May; 18(3):65-75. PubMed ID: 2657803
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel intracellular mediator of adiponectin secretion from adipocytes.
    Omatsu-Kanbe M; Matsuura H
    J Physiol; 2014 Dec; 592(23):5141. PubMed ID: 25448182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.